Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to demonstrate the antidiarrheal efficacy of colloidal silicon dioxide in tablet dosage form (Carbowhite) in patients with acute diarrhea.


Clinical Trial Description

Background: Diarrhea is a medical condition characterized by frequent stool, more than 3 times (and more than 5-7 times in newborns) within the last 24 hours, and/or loose stool. The fecal matter is liquid, its daily mass exceeds 200 g per day, and water content reaches 95%.

Objectives: To demonstrate the antidiarrheal efficacy of colloidal silicon dioxide in tablet dosage form (Carbowhite) in patients with acute diarrhea.

Methods: A randomized clinical trial, double-blind, placebo-controlled, multi-center. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03633344
Study type Interventional
Source Omnifarma Kiev LLC
Contact
Status Completed
Phase Phase 2
Start date March 29, 2016
Completion date October 7, 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05677282 - Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct Phase 4
Recruiting NCT04782037 - Effectiveness of Folic Acid Supplementation in Acute Watery Diarrhea Among Children Under 5 Years of Age Phase 4
Completed NCT04061538 - Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of Age N/A
Completed NCT03988257 - The Effectiveness of Pleuran in Treatment of Acute Gastroenteritis in Children Phase 4
Recruiting NCT04529434 - Star Homes Project 2 N/A
Not yet recruiting NCT05722119 - GastroIntestinal Panel in Kidney Transplant Patients Phase 3